Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIONEER: EP2006 vs Neupogen in Breast Cancer
NCT01519700Phase 3Completed
- Sponsor
- Sandoz
- Start
- Dec 2011
- Primary completion
- Jun 2013
- Modality
- Cytokines & Interferons
- Countries
- 6
01
Overview
A Phase 3 trial of filgrastim in neutropenia, sponsored by Sandoz. Started Dec 2011; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01519700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519700.